🏛️ Verified NIH Record • Updated 2026-04-30
Early Detection of Lung Cancer (NCT03181256)
Early Detection of Lung Cancer in the Medically Underserved Population
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Vanderbilt-Ingram Cancer Center
🩺 Plain-English Summary (8th-Grade Level)
This research trial studies the long term follow-up for early detection of lung cancer in current or former smokers. Following up on smokers by collecting and analyzing specimens in the laboratory, performing chest computed tomography (CT) scans, as well as reviewing medical records may help doctors detect lung cancer at an earlier stage.
Who can join: Review the eligibility criteria below.
Location: Vanderbilt-Ingram Cancer Center — Nashville, Tennessee
Age range: 55 Years to 80 Years
🧪 Interventions in This Study
- Biospecimen Collection (PROCEDURE)
- Biospecimen collection (PROCEDURE)
- Biospecimen collection (PROCEDURE)
- Biospecimen collection (PROCEDURE)
- Biospecimen collection (PROCEDURE)
- Pulmonary Function Test (PROCEDURE)
- Computed Tomography (CT) (PROCEDURE)
- Laboratory Biomarker (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Vanderbilt-Ingram Cancer Center — Nashville, Tennessee
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Lung Cancer
- Implementation Strategies for Monitoring Adherence in Real Time — Philadelphia, Pennsylvania
- Improving Utilization of Lung Cancer Screening in Underserved PA Populations — Allentown, Pennsylvania
- Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer Setting — Houston, Texas
- Testing the Engaged Approach to Lung Cancer Screening — Denver, Colorado
- Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer — Boston, Massachusetts
Explore by condition: All Lung Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.